News and Events - Page 2 of 10 - Precision Biologics

06AugAugust 6, 2024

Dr. Philip M. Arlen to Chair and Present at Cambridge Healthtech Institute Immuno-Oncology Summit 2024, August 7-9, 2024, Philadelphia, PA

Precision Biologics’ CEO, Dr. Philip M. Arlen, to Chair Therapeutic Cancer Vaccine Program, and lead...

01AugAugust 1, 2024

Genetic Engineering and Biotechnology News (GEN) news article highlights Precision Biologics, Inc., August 1, 2024...

22JulJuly 22, 2024

Precision Biologics awarded new US Patent on its lead monoclonal antibody NEO-201 for regulatory T-cell...

31MayMay 31, 2024

Precision Biologics presents new data from ongoing clinical trial combining NEO-201 with pembrolizumab at the...

29AprApril 29, 2024

7th INTERNATIONAL NEOANTIGEN SUMMIT, AMSTERDAM, NETHERLANDS, APRIL 29 - May 1, 2024 Accelerating Robust, Durable &...

25AprApril 25, 2024

IMMUNO 2024, LONDON, UK, APRIL 25 - 26, 2024 Day 1: Track 1: Discovery & Development:...

15AprApril 15, 2024

05AprApril 5, 2024

Precision Biologics will present recent scientific data at the American Association for Cancer Research (AACR)...

12DecDecember 12, 2023

Dr. Philip M. Arlen, President & CEO of Precision Biologics, Inc. will deliver a scientific...

24NovNovember 24, 2023

Natural killer (NK) cells are cellular components of the innate immune system that can recognize...